Unimpaired function of a naturally occurring C terminally truncated vif gene product of human immunodeficiency virus type 1

被引:13
作者
Ochsenbauer, C
Bosch, V
Oelze, I
Wieland, U
机构
[1] DEUTSCH KREBSFORSCHUNGSZENTRUM,D-69120 HEIDELBERG,GERMANY
[2] UNIV COLOGNE,INST VIROL,D-50935 COLOGNE,GERMANY
关键词
D O I
10.1099/0022-1317-77-7-1389
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
In similar to 10 % of natural human immunodeficiency virus 1 (HIV-1) vif gene populations, sequences of shortened vif open reading frames with premature stop codons have been found. Here we report the functional analysis of two patient-derived vif genes. Vif45-2 encodes a C terminally truncated Vif protein of only 173 instead of 192 amino acids and additionally contains several rare amino acid substitutions which are in part shared by vifAG5-5. HIV-1 pNL4-3-derived recombinant A45-2 and A65-5 virions were fully infectious in H9 cells and human PBMC, both known to be non-permissive for vif-defective HIV-1. Furthermore, A45-2 virions produced in primary human monocyte-derived macrophages were infectious for MT-4 cells. This study unequivocally demonstrates that the C-terminal region (19 amino acids) of the Vif protein is dispensable for Vif function in the in vitro cell culture systems employed. Additionally, we investigated whether the Vif protein might be phosphorylated in vivo and obtained no evidence for this.
引用
收藏
页码:1389 / 1395
页数:7
相关论文
共 22 条
[1]   PROSITE - A DICTIONARY OF SITES AND PATTERNS IN PROTEINS [J].
BAIROCH, A .
NUCLEIC ACIDS RESEARCH, 1992, 20 :2013-2018
[2]   HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF(-) MUTANT PARTICLES FROM RESTRICTIVE CELLS - ROLE OF VIF IN CORRECT PARTICLE ASSEMBLY AND INFECTIVITY [J].
BORMAN, AM ;
QUILLENT, C ;
CHARNEAU, P ;
DAUGUET, C ;
CLAVEL, F .
JOURNAL OF VIROLOGY, 1995, 69 (04) :2058-2067
[3]   MUTATIONAL ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ENV GENE-PRODUCT PROTEOLYTIC CLEAVAGE SITE [J].
BOSCH, V ;
PAWLITA, M .
JOURNAL OF VIROLOGY, 1990, 64 (05) :2337-2344
[4]  
COURCOUL M, 1995, J VIROL, V69, P2086
[5]   HIV-1 INFECTION OF NONDIVIDING CELLS [J].
FREED, EO ;
MARTIN, MA .
NATURE, 1994, 369 (6476) :107-108
[6]  
GABUZDA DH, 1994, J ACQ IMMUN DEF SYND, V7, P908
[7]   REV ACTIVATES EXPRESSION OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF-GENE AND VPR-GENE PRODUCTS [J].
GARRETT, ED ;
TILEY, LS ;
CULLEN, BR .
JOURNAL OF VIROLOGY, 1991, 65 (03) :1653-1657
[8]   BIOLOGICAL-ACTIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIF REQUIRES MEMBRANE TARGETING BY C-TERMINAL BASIC DOMAINS [J].
GONCALVES, J ;
SHI, B ;
YANG, XY ;
GABUZDA, D .
JOURNAL OF VIROLOGY, 1995, 69 (11) :7196-7204
[9]   SUBCELLULAR-LOCALIZATION OF THE VIF PROTEIN OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 [J].
GONCALVES, J ;
JALLEPALLI, P ;
GABUZDA, DH .
JOURNAL OF VIROLOGY, 1994, 68 (02) :704-712
[10]   GROWTH ABILITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 AUXILIARY GENE MUTANTS IN PRIMARY BLOOD MACROPHAGE CULTURES [J].
KAWAMURA, M ;
ISHIZAKI, T ;
ISHIMOTO, A ;
SHIODA, T ;
KITAMURA, T ;
ADACHI, A .
JOURNAL OF GENERAL VIROLOGY, 1994, 75 :2427-2431